Education
About Us
Working with TipRanks
Follow Us
ConvaTec (GB:CTEC)
LSE:CTEC
CTEC Stock Chart & Stats
239.20p
1.06p(0.47%)
At close: 4:00 PM EST
239.20p
1.06p(0.47%)
Day’s Range― - ―
52-Week Range218.00p - 311.20p
Previous CloseN/A
Volume85.46K
Average Volume (3M)6.27M
Market Cap
£4.80B
Enterprise Value6.82B
Total Cash (Recent Filing)£95.70M
Total Debt (Recent Filing)£1.34B
Price to Earnings (P/E)29.6
Beta0.76
Next Earnings
Feb 25, 2026EPS Estimate
0.08Last Dividend Ex-Date
Aug 21, 2025Dividend Yield2.11%
Share Statistics
EPS (TTM)0.06
Shares Outstanding1,982,382,900
10 Day Avg. Volume5,278,857
30 Day Avg. Volume6,266,139
Financial Highlights & Ratios
PEG Ratio0.65
Price to Book (P/B)3.36
Price to Sales (P/S)2.48
P/FCF Ratio20.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£311.33Price Target Upside30.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial GuidanceOverall FY25 guidance has been reiterated, with adjusted operating profit margin expected at 22.0-22.5%, despite the impact of tariff headwinds.
Revenue GrowthConvatec has reported organic revenue growth of 6.3% in line with its prior guidance, which is now narrowed to 6.0-6.5%.
Share Buyback ProgramConvaTec announced a non-discretionary share buyback program to return up to $300 million of surplus capital to shareholders.
Bears Say
Leverage IncreaseThe share buyback program would take ConvaTec's FY25 leverage from 1.8x to 2.2x, which is above the company's leverage target of 2x.
ConvaTec News
CTEC FAQ
What was ConvaTec’s price range in the past 12 months?
ConvaTec lowest share price was 218.00p and its highest was 311.20p in the past 12 months.
What is ConvaTec’s market cap?
ConvaTec’s market cap is £4.80B.
When is ConvaTec’s upcoming earnings report date?
ConvaTec’s upcoming earnings report date is Feb 25, 2026 which is in 98 days.
How were ConvaTec’s earnings last quarter?
ConvaTec released its earnings results on Jul 29, 2025. The company reported 0.061p earnings per share for the quarter, beating the consensus estimate of 0.06p by <0.001p.
Is ConvaTec overvalued?
According to Wall Street analysts ConvaTec’s price is currently Undervalued.
Does ConvaTec pay dividends?
ConvaTec pays a Semiannually dividend of 1.399p which represents an annual dividend yield of 2.11%. See more information on ConvaTec dividends here
What is ConvaTec’s EPS estimate?
ConvaTec’s EPS estimate is 0.08.
How many shares outstanding does ConvaTec have?
ConvaTec has 1,982,382,900 shares outstanding.
What happened to ConvaTec’s price movement after its last earnings report?
ConvaTec reported an EPS of 0.061p in its last earnings report, beating expectations of 0.06p. Following the earnings report the stock price went up 2.346%.
Which hedge fund is a major shareholder of ConvaTec?
Currently, no hedge funds are holding shares in GB:CTEC
ConvaTec Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
£311.33 (30.15% Upside)
£311.33 (30.15% Upside)
Insider Transactions
Bought Shares
Worth £167.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
6.61%
12-Months-Change
Fundamentals
Return on Equity
12.73%
Trailing 12-Months
Asset Growth
-4.01%
Trailing 12-Months
Company Description
ConvaTec
ConvaTec (CTEC) is a global medical technology company specializing in the development and marketing of innovative products and services for the management of chronic conditions, particularly in the areas of wound care, ostomy care, continence care, and infusion devices. The company focuses on enhancing the quality of life for patients and caregivers through its comprehensive range of healthcare solutions, including advanced wound dressings, ostomy appliances, and products for managing urinary incontinence and diabetes.
CTEC Stock 12 Month Forecast
Average Price Target
311.33p
▲(30.15% Upside)
Technical Analysis
Advanced Medical Solutions
―
Craneware
―
Hikma Pharmaceuticals
―
Spire Healthcare
―
Smith & Nephew
―
Options Prices
Currently, No data available
---